Revalesio Corporation, located in Tacoma, WA, is partnering with leaders in biomedical research around the globe to harness the benefits of fluid modification via turbulent Taylor-Couette-Poiseuille (TCP) flow. Revalesio’s patented application of fluid cavitation within a TCP flow environment has resulted in ground breaking publications in the disciplines of physical chemistry as well as biomedical science.
Revalesio is dedicated to commercializing its discoveries through a global drug discovery research and development program that holds significant promise in the area of neurological disorders.
